BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 19528812)

  • 1. Assessment of the ion channel-blocking profile of the novel combined ion channel blocker AZD1305 and its proarrhythmic potential versus dofetilide in the methoxamine-sensitized rabbit in vivo.
    Carlsson L; Andersson B; Linhardt G; Löfberg L
    J Cardiovasc Pharmacol; 2009 Jul; 54(1):82-9. PubMed ID: 19528812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beat-by-beat QT interval variability, but not QT prolongation per se, predicts drug-induced torsades de pointes in the anaesthetised methoxamine-sensitized rabbit.
    Jacobson I; Carlsson L; Duker G
    J Pharmacol Toxicol Methods; 2011; 63(1):40-6. PubMed ID: 20451633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced ventricular proarrhythmic potential of the novel combined ion-channel blocker AZD1305 versus dofetilide in dogs with remodeled hearts.
    Johnson DM; de Jong MM; Crijns HJ; Carlsson LG; Volders PG
    Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):201-9. PubMed ID: 22080293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the proarrhythmic potential of the novel antiarrhythmic agent AZD7009 and dofetilide in experimental models of torsades de pointes.
    Wu Y; Carlsson L; Liu T; Kowey PR; Yan GX
    J Cardiovasc Electrophysiol; 2005 Aug; 16(8):898-904. PubMed ID: 16101634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vernakalant is devoid of proarrhythmic effects in the complete AV block dog model.
    Varkevisser R; van der Heyden MA; Tieland RG; Beekman JD; Vos MA
    Eur J Pharmacol; 2013 Nov; 720(1-3):49-54. PubMed ID: 24211677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beat-to-Beat variability of repolarization determines proarrhythmic outcome in dogs susceptible to drug-induced torsades de pointes.
    Thomsen MB; Volders PG; Beekman JD; Matz J; Vos MA
    J Am Coll Cardiol; 2006 Sep; 48(6):1268-76. PubMed ID: 16979017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new method to calculate the beat-to-beat instability of QT duration in drug-induced long QT in anesthetized dogs.
    van der Linde H; Van de Water A; Loots W; Van Deuren B; Lu HR; Van Ammel K; Peeters M; Gallacher DJ
    J Pharmacol Toxicol Methods; 2005; 52(1):168-77. PubMed ID: 15935709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium antagonist property of CPU228, a dofetilide derivative, contributes to its low incidence of torsades de pointes in rabbits.
    Huang ZJ; Dai DZ; Li N; Na T; Ji M; Dai Y
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):310-7. PubMed ID: 17324143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the Na+/Ca2+ exchanger, I(Na) and I(CaL) in the genesis of dofetilide-induced torsades de pointes in isolated, AV-blocked rabbit hearts.
    Farkas AS; Makra P; Csík N; Orosz S; Shattock MJ; Fülöp F; Forster T; Csanády M; Papp JG; Varró A; Farkas A
    Br J Pharmacol; 2009 Mar; 156(6):920-32. PubMed ID: 19222480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic properties of a rapid delayed-rectifier current activator in rabbit models of acquired long QT syndrome.
    Diness TG; Yeh YH; Qi XY; Chartier D; Tsuji Y; Hansen RS; Olesen SP; Grunnet M; Nattel S
    Cardiovasc Res; 2008 Jul; 79(1):61-9. PubMed ID: 18367457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proarrhythmic electrical remodelling is associated with increased beat-to-beat variability of repolarisation.
    Thomsen MB; Oros A; Schoenmakers M; van Opstal JM; Maas JN; Beekman JD; Vos MA
    Cardiovasc Res; 2007 Feb; 73(3):521-30. PubMed ID: 17196569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
    Bril A; Gout B; Bonhomme M; Landais L; Faivre JF; Linee P; Poyser RH; Ruffolo RR
    J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Models of torsades de pointes: effects of FPL64176, DPI201106, dofetilide, and chromanol 293B in isolated rabbit and guinea pig hearts.
    Cheng HC; Incardona J
    J Pharmacol Toxicol Methods; 2009; 60(2):174-84. PubMed ID: 19524054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial-specific drug AVE0118 is free of torsades de pointes in anesthetized dogs with chronic complete atrioventricular block.
    Oros A; Volders PG; Beekman JD; van der Nagel T; Vos MA
    Heart Rhythm; 2006 Nov; 3(11):1339-45. PubMed ID: 17074641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RSD1235 blocks late INa and suppresses early afterdepolarizations and torsades de pointes induced by class III agents.
    Orth PM; Hesketh JC; Mak CK; Yang Y; Lin S; Beatch GN; Ezrin AM; Fedida D
    Cardiovasc Res; 2006 Jun; 70(3):486-96. PubMed ID: 16545351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beat-to-Beat Variability in Preload Unmasks Latent Risk of Torsade de Pointes in Anesthetized Chronic Atrioventricular Block Dogs.
    Stams TR; Oosterhoff P; Heijdel A; Dunnink A; Beekman JD; van der Nagel R; van Rijen HV; van der Heyden MA; Vos MA
    Circ J; 2016 May; 80(6):1336-45. PubMed ID: 27151565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late na(+) current inhibition by ranolazine reduces torsades de pointes in the chronic atrioventricular block dog model.
    Antoons G; Oros A; Beekman JD; Engelen MA; Houtman MJ; Belardinelli L; Stengl M; Vos MA
    J Am Coll Cardiol; 2010 Feb; 55(8):801-9. PubMed ID: 20170820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined pharmacological block of I(Kr) and I(Ks) increases short-term QT interval variability and provokes torsades de pointes.
    Lengyel C; Varró A; Tábori K; Papp JG; Baczkó I
    Br J Pharmacol; 2007 Aug; 151(7):941-51. PubMed ID: 17533421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of a KCNH2 polymorphism (R1047 L) in dofetilide-induced Torsades de Pointes.
    Sun Z; Milos PM; Thompson JF; Lloyd DB; Mank-Seymour A; Richmond J; Cordes JS; Zhou J
    J Mol Cell Cardiol; 2004 Nov; 37(5):1031-9. PubMed ID: 15522280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potassium and calcium current blocking properties of the novel antiarrhythmic agent H 345/52: implications for proarrhythmic potential.
    Amos GJ; Abrahamsson C; Duker G; Hondeghem L; Palmer M; Carlsson L
    Cardiovasc Res; 2001 Feb; 49(2):351-60. PubMed ID: 11164845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.